VEGFA and prostate carcinoma: Recent insights into the functional role the β2-adrenoceptor plays in angiogenesis in prostate cancer revealed a dose-dependent increase in VEGF expression in LNCaP human prostate cancer cells, upon stimulation of β2-adrenoceptor via epinephrine [154].